Please assess the completion status of the following clinical trial:

Trial Title: Optimizing Pacing Therapy by Using Multi-Programmable Pulse Generators for Cardiac Resynchronization Pacing (CRT-P)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. 18 years or above, or above legal age to give informed consent specific to state and national law~2. Willing and capable of providing informed consent~3. Planned to be implanted or replaced with a VISIONIST Ingenio 2 CRT-P device~4. Planned to be implanted with a 3-lead CRT-P system~5. Planned to be connected to the remote data collection through the Latitude® system~6. Able to do a 6 minute walk test~7. Maximum sensor rate of age predicted maximal heart rate (APMHR) 80% should be clinically acceptable~8. Willing and capable of participating in all visits associated with this study at an approved clinical study center and at the intervals defined-~Exclusion Criteria:~1. Documented life expectancy of less than 12 months~2. Currently on the active heart transplant list~3. Enrolled in any other concurrent study without prior written approval from Boston Scientific, with the exception of local mandatory governmental registries and observational studies/registries that are not in conflict and do not affect the following:~   * Schedule of procedures for the Rally CRT-P Study (i.e., should not cause additional or missed visits)~  * Rally CRT-P Study outcomes (i.e., involve medications that could affect the heart rate of the subject)~  * Conduct of the Rally CRT-P Study per Good Clinical Practice (GCP)/ International Standard Organization (ISO) 14155:2011/ local regulations as applicable~4. In chronic atrial fibrillation~5. APMHR needs to be programmed \< 80%.~6. Not planned to receive a functional atrial lead~7. Per the implanting physician's discretion, subject is not a suitable candidate to receive the study device as determined during the implant procedure~8. Women of childbearing potential who are or might be pregnant at the time of study enrollment~9. Unwilling or unable to participate in all scheduled study follow up visits at an approved study center~10. Does not anticipate being a resident of the area for the scheduled duration of the trial. -

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CRT-P indicated patients (Type: None): Planned to be implanted with a 3-lead CRT-P system and connected to the remote data collection through the Latitude® system

Based on this trial design, predict the completion outcome and termination type (if applicable).